Literature DB >> 21458130

[Left dominant arrhythmogenic cardiomyopathy caused by a novel nonsense mutation in desmoplakin].

Josep Navarro-Manchón1, Elena Fernández, Begoña Igual, Angeliki Asimaki, Petros Syrris, Joaquín Osca, Antonio Salvador, Esther Zorio.   

Abstract

Left dominant arrhythmogenic cardiomyopathy (LDAC) exhibits characteristic phenotypic and genetic features which were found in the five Spanish family members described in this study. Triggered by a cold, a young man presented with a ventricular tachycardia of left ventricular origin and left ventricular late gadolinium enhancement. His resting ECG showed low potentials, delayed ventricular depolarization (inferior and V4-V6 leads) and atrioventricular conduction disturbances. His endomyocardial biopsy revealed myocyte loss with interstitial fibrosis. Despite the initial diagnosis of myocarditis, familial screening was pivotal in confirming the diagnosis of LDAC. A novel nonsense mutation in the desmoplakin gene (Q1866X) and the truncated protein which it produces were observed in skin samples.
Copyright © 2010 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458130     DOI: 10.1016/j.recesp.2010.10.020

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  6 in total

1.  Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Eric D Smith; Neal K Lakdawala; Nikolaos Papoutsidakis; Gregory Aubert; Andrea Mazzanti; Anthony C McCanta; Prachi P Agarwal; Patricia Arscott; Lisa M Dellefave-Castillo; Esther E Vorovich; Kavitha Nutakki; Lisa D Wilsbacher; Silvia G Priori; Daniel L Jacoby; Elizabeth M McNally; Adam S Helms
Journal:  Circulation       Date:  2020-05-06       Impact factor: 29.690

2.  Arrhythmogenic cardiomyopathy with left ventricular involvement versus ischemic heart disease: lessons learned from the family study and the reviewed autopsy of a young male.

Authors:  Pilar Molina; Jorge Sanz-Sánchez; Manuel Fenollosa; Marina Martínez-Matilla; Juan Giner; Esther Zorio
Journal:  Forensic Sci Res       Date:  2019-08-19

3.  A case report of arrhythmogenic ventricular cardiomyopathy presenting with sustained ventricular tachycardia arising from the right and the left ventricles before structural changes are documented.

Authors:  Bernard Belhassen; Haim Shmilovich; Eyal Nof; Anat Milman
Journal:  Eur Heart J Case Rep       Date:  2020-01-25

Review 4.  Genetic Background and Clinical Features in Arrhythmogenic Left Ventricular Cardiomyopathy: A Systematic Review.

Authors:  Riccardo Bariani; Ilaria Rigato; Marco Cason; Maria Bueno Marinas; Rudy Celeghin; Kalliopi Pilichou; Barbara Bauce
Journal:  J Clin Med       Date:  2022-07-25       Impact factor: 4.964

Review 5.  Cell models of arrhythmogenic cardiomyopathy: advances and opportunities.

Authors:  Elena Sommariva; Ilaria Stadiotti; Gianluca L Perrucci; Claudio Tondo; Giulio Pompilio
Journal:  Dis Model Mech       Date:  2017-07-01       Impact factor: 5.758

6.  Monozygotic twins with myocarditis and a novel likely pathogenic desmoplakin gene variant.

Authors:  Antheia Kissopoulou; Eva Fernlund; Christina Holmgren; Eira Isaksson; Jan-Erik Karlsson; Henrik Green; Jon Jonasson; Rada Ellegård; Hanna Klang Årstrand; Anneli Svensson; Cecilia Gunnarsson
Journal:  ESC Heart Fail       Date:  2020-04-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.